Clinical Research
Copyright ©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 7, 2007; 13(41): 5440-5445
Published online Nov 7, 2007. doi: 10.3748/wjg.v13.i41.5440
Table 1 Clinical characteristics of patients at enrollment
Patient No.Age(yr)GenderALT(nkat/L)HBV DNA(103 LGE/L)Type of response(end of treatment)
Group A
148M896.8Responder
251M1587.3Responder
344M868.3Responder
441M4648.0Responder
539M1224.8Responder
667M1428.1Non-responder
752M1408.3Non-responder
826M694.8Non-responder
952M467.6Non-responder
1033M395.4Non-responder
1124F4588.7Non-responder
1227F518.5Non-responder
1352F807.4Non-responder
1437F576.8Non-responder
Group B
1542F437.2No treatment
1633F198.1No treatment
1751M1383.9No treatment
1831M577.1No treatment
1929M797.1No treatment
2044M467.2No treatment
Table 2 SI of T cells against HBV antigens from combination therapy patients
Patient No.12 mo
24 mo
PHAHBsAgpreS1HBeAgHBcAgPHAHBsAgpreS1HBeAgHBcAg
138.113.513.213.914.218.214.113.514.114.81
220.313.414.014.114.417.713.213.04.414.71
319.513.213.914.814.114.913.513.714.715.11
432.314.317.817.217.919.614.016.918.118.81
515.511.92.32.01.78.413.513.514.314.41
612.810.41.21.51.44.911.11.31.51.2
750.212.11.92.02.038.811.71.81.61.6
84.911.82.11.71.9NTNTNTNTNT
966.312.01.51.81.612.011.51.21.51.3
1056.612.32.32.02.118.312.02.11.81.9
1123.811.11.01.11.28.711.00.81.21.3
1219.211.41.21.41.34.611.11.51.11.2
1342.011.81.51.91.76.911.51.31.41.5
1421.812.22.42.22.64.912.02.31.92.0